• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.12% Nasdaq Up0.71%

    Halozyme Therapeutics, Inc. (HALO)

    -NMS
    16.86 0.00(0.00%) Apr 24, 4:00PM EDT
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Net Income (68,375) (83,479) (53,552)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation3,219  2,343  1,079  
    Adjustments To Net Income17,532  9,694  8,365  
    Changes In Accounts Receivables(52)6,606  (13,441)
    Changes In Liabilities659  17,137  (256)
    Changes In Inventories(236)(3,499)(2,103)
    Changes In Other Operating Activities(265)1,859  (4,371)
    Total Cash Flow From Operating Activities (47,518) (49,339) (64,279)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(1,368)(2,297)(1,413)
    Investments(31,583)(45,572) -  
    Other Cash flows from Investing Activities -   -   -  
    Total Cash Flows From Investing Activities (32,951) (47,869) (1,413)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock114,501  5,079  83,157  
    Net Borrowings -  19,985  29,661  
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 114,501   25,064   112,818  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents 34,032   (72,144) 47,126  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.